Generic blood thinner tested against Brand-Name in healthy volunteers
NCT ID NCT06043297
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tested whether a generic version of the blood thinner apixaban works the same as the brand-name version. Thirty healthy adults took a single dose of each pill under fasting conditions. The goal was to check if the two drugs are bioequivalent, meaning they are absorbed and processed by the body in a similar way.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTITHROMBIC DRUG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lambda Therapeutic Research Ltd.
Ahmedabad, Gujarat, 382481, India
Conditions
Explore the condition pages connected to this study.